Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with chronic noncancer pain severe enough to require continuous opioid therapy (a score of at least 5 in pain right now on a 11 point numeric rating scale) who have never received an opioid or are currently treated with a weak opioid, and who experience insufficient pain control.~Exclusion Criteria:~* Patients who have been treated with strong opioids (including hydromorphone and oxycodone) within the last 4 weeks prior to study inclusion or who will probably undergo any treatment (e.g. neurological techniques, surgery) within the next 6 months, which may abruptly alter degree or nature of pain experienced~* patients with a history of disease(s), current illness, or therapy which would preclude them from participation in the study~* and patients who are pregnant or nursing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oxycodone (Type: ACTIVE_COMPARATOR): None
- OROS hydromorphone HCl (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).